首页|彩超、超微血流显像技术和肿瘤标志物在乳腺肿块良性恶性诊断中的价值

彩超、超微血流显像技术和肿瘤标志物在乳腺肿块良性恶性诊断中的价值

扫码查看
目的 探讨彩色多普勒超声、超微血流显像技术和肿瘤标志物在乳腺肿块良性恶性诊断中的价值.方法 选取2022年2月至2024年3月于新乡医学院第一附属医院就诊的乳腺肿块患者88例,所有患者分别接受彩色多普勒超声和超微血流显像技术检查,并测定糖类抗原153(CA153)和糖类抗原125(CA125)的血清水平.以病理学诊断结果为金标准,分析彩色多普勒超声、超微血流显像技术和CA153+CA125单独及联合诊断的诊断效能.计量数据比较采用t检验.结果 病理结果显示,88例乳腺肿块患者中,良性乳腺肿块的患者为40例,恶性乳腺肿块的患者为48例.彩色多普勒超声诊断乳腺良恶性肿块的灵敏度为70.83%(34/48)、特异度为70.00%(28/40)、准确率为70.45%(62/88);超微血流显像技术诊断乳腺良恶性肿块的灵敏度为83.33%(40/48)、特异度为82.50%(33/40)、准确率为82.95%(73/88).恶性乳腺肿块患者的CA153[(54.21±21.86)U/ml]和CA125[(43.73±9.88)U/ml]蛋白水平明显高于良性乳腺肿块患者[(17.99±7.37)、(26.47±9.78)U/ml,t=9.90、8.11,P<0.05];CA153 和 CA125 联合诊断乳腺良恶性肿块的灵敏度为79.17%(38/48)、特异度为80.00%(32/40)、准确率为79.55%(70/88).彩超、超微血流显像技术、CA153+CA125联合诊断乳腺良恶性肿块的灵敏度为95.83%(46/48)、特异度为97.50%(39/40)、准确率为96.59%(85/88).联合诊断的灵敏度、特异度和准确率均明显高于彩色多普勒超声(Z=3.29、2.00、2.47,P<0.05)、超微血流显像技术(Z=2.00、2.24、2.99,P<0.05)和CA153+CA125(Z=2.47、2.48、3.49,P<0.05)单项检测的灵敏度、特异度和准确率.结论 彩色多普勒超声、超微血流显像技术和肿瘤标志物联合诊断在乳腺肿块的良恶性鉴别中具有较高的灵敏度、特异性和准确度,可显著提升良恶性肿块的诊断效能.
Value of color Doppler ultrasound,super microvascular imaging and tumor markers in the diagno-sis of benign and malignant breast masses
Objective To investigate the value of color Doppler ultrasound,super microvascular imaging and tumor markers in the diagnosis of benign and malignant breast masses.Methods 88 patients with breast mass admitted to the first affiliated hospital of Xinxiang medical college from February 2022 to March 2024 were selected.All patients were examined by color Doppler ultrasound and super microvascular imaging,respectively,and the serum levels of carbohydrate antigen 153(CA153)and carbohydrate antigen 125(CA125)were determined.The diagnostic efficacy of color Doppler ultrasound,super microvascular imaging and CA153+CA125 alone and in combination were analyzed with pathological diagnosis as the gold standard.The measurement data were compared by t-test.Results The pathological results showed that among the 88 patients with breast mass,40 were benign and 48 were malignant.The sensitivity,speci-ficity and accuracy of color Doppler ultrasound were 70.83%(34/48),70.00%(28/40)and 70.45%(62/88)in the diagnosis of benign and malignant breast masses.The sensitivity,specificity and accuracy of super microvascular imaging were 83.33%(40/48),82.50%(33/40)and 82.95%(73/88)in the diagnosis of benign and malignant breast masses.The protein levels of CA153[(54.21±21.86)U/ml]and CA125[(43.73±9.88)U/ml]in patients with malignant breast mass were significantly higher than those in patients with benign breast mass[(17.99±7.37),(26.47±9.78)U/ml,t=9.90,8.11,P<0.05];The sensitivity,specificity and accuracy of CA153 and CA125 in the diagnosis of benign and malig-nant breast masses were 79.17%(38/48),80.00%(32/40)and 79.55%(70/88)respectively.The sensitivity,specificity and accuracy of the three methods in the diagnosis of benign and malignant breast masses were 95.83%(46/48),97.50%(39/40)and 96.59%(85/88)respectively.The sensitivity,specificity and accuracy of combined diagnosis were significantly higher than those of color Doppler ultra-sound(Z=3.29,2.00,2.47,P<0.05),super microvascular imaging(Z=2.00,2.24,2.99,P<0.05)and CA153+CA125(Z=2.47,2.48,3.49,P<0.05)single detection.Conclusion The com-bined diagnosis of color Doppler ultrasound,super microvascular imaging and tumor markers has high sen-sitivity,specificity and accuracy in the differentiation of benign and malignant breast masses,and can sig-nificantly improve the diagnostic efficiency of benign and malignant breast masses.

Color Doppler ultrasoundSuper microvascular imagingTumor markersBreast masses

王黎伟、王志芬、李广俊、鲁广建

展开 >

新乡医学院第一附属医院超声科,卫辉 453100

新乡医学院第一附属医院静脉通路门诊,卫辉 453100

新乡医学院第一附属医院普通外科,卫辉 453100

新乡医学院第一附属医院检验科,卫辉 453100

展开 >

彩色多普勒超声 超微血流显像技术 肿瘤标志物 乳腺肿块

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(11)